Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.

By Andrea Cipriani, T. Furukawa, Georgia Salanti, A. Chaimani, L. Atkinson, Y. Ogawa, S. Leucht, H. Ruhé, Erick H Turner, Julian P. T. Higgins and 8 more. Focus, 2018

2,646 citations recorded by the source corpus.

(Reprinted with permission from Lancet 2018; 391:1357-66).

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A Social Media Study on the Effects of Psychiatric Medication Use (2019, background): “On the other hand, Duloxetine was associated with positive symptomatic outcomes, as also found in clinical studies (Cipriani et al. 2018).”
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review (2019, background): “All practice implications have been changed: although studies on the efficacy of citalopram, paroxetine, and sertraline for the treatment of PD depression report conflicting data for efficacy,(2) and although there were no placebo arms in the studies on fluoxetine for the treatment of PD depression,”
Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials (2024, background): “6 Those reviews include more than 500 studies comparing psychological or drug interventions with controls.”